2015
DOI: 10.4155/tde.15.62
|View full text |Cite
|
Sign up to set email alerts
|

Identifying Present Challenges to Reliable Future Transdermal Drug Delivery Products

Abstract: Transdermal systems have become an accepted means of drug delivery, offering clinical benefits over other dosage forms. Although transdermal delivery has been very successful as a controlled release technology platform, there are a number of challenges that prevent this delivery route from achieving its fullest commercial potential. Additionally, beginning in 1997, transdermal drug delivery companies aligned with life science industries to deliver large molecules, peptides and proteins through the skin, which … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 21 publications
0
4
0
Order By: Relevance
“…), and biological factors (site of application and variability in skin permeation) that should be overcome. 10
Figure 3 Nanoparticles as novel topical drug delivery system (TDDS) used to improve skin penetration, dermal and transdermal delivery.
…”
Section: Nanocarriers and Nanoparticlesmentioning
confidence: 99%
“…), and biological factors (site of application and variability in skin permeation) that should be overcome. 10
Figure 3 Nanoparticles as novel topical drug delivery system (TDDS) used to improve skin penetration, dermal and transdermal delivery.
…”
Section: Nanocarriers and Nanoparticlesmentioning
confidence: 99%
“…However, the stratum corneum (SC), a ‘bricks and mortar' structure, prevents entry of harmful xenobiotics as well as most therapeutic compounds into the body [5]. The lipophilic and intact SC layers allow only small (< 500 Da) and moderately lipophilic molecules (logP 1-3) to diffuse through passively [6]. Irrespective of dermal or transdermal delivery, it is essential to overcome the SC barriers, leading to emerging of a series of passive and active strategies.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, the inclusion of TDDS will boost patients' self-reliability by significantly reducing the frequency of hospital visits and the cost of joint treatment 67 The earlier pharmaceutical compound that can't be converted into TDDS products can now be converted into TDDS which can be applied to the skin with the help of this technology 68 . Trans Derma Sal® technology is used in Fentos ® tape.…”
Section: Market Segmentationmentioning
confidence: 99%